<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Auxilium Pharmaceuticals Inc. | Company News & Executive Profiles - AUXL | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Auxilium Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="17" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Auxilium Pharmaceuticals, Inc. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-358131.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from the line of Marshall Urist with Morgan Stanley. Please proceed. Marshall Urist - Morgan Stanley  Yeah, hi guys, good morning. Couple of things, first one just from your comments on the &#8211; on the Pfizer, Pfizer said in...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 28 Oct 2009 13:59:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/pricing+strategy.html"><![CDATA[Pricing Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">AUXL,MS,PFE</category>
	</item>
	<item>
		<title><![CDATA[Auxilium Inches Toward FDA Approval for Xiaflex]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F166413-auxilium-inches-toward-fda-approval-for-xiaflex%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   Auxilium Pharma AUXL is currently awaiting a decision from the U.S. Food and Drug Administration FDA on its key pipeline candidate, Xiaflex, which is under FDA review for the treatment of Dupuytren&#8217;s Contracture. In September, Auxilium received a major boost in the form of a favorable...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 14 Oct 2009 04:24:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">AUXL,PFE</category>
	</item>
	<item>
		<title><![CDATA[Auxilium Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-299508.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Eric Schmidt from Cowen & Co.   Eric Schmidt - Cowen & Co.  Good morning, congratulations on the acceptance for the PLA.  My question is on the review process.  It seems like the FDA has...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 06 May 2009 11:50:28 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/piper+jaffray+%2526+co..html"><![CDATA[Piper Jaffray & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="tickers">AUXL</category>
	</item>
	<item>
		<title><![CDATA[Auxilium Pharmaceuticals Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-270552.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operators Instructions. Your first question comes from the line of Marshall Urist from Morgan Stanley. Please proceed. Marshall Urist - Morgan Stanley Yeah, hey guys Good morning. First question is, can you just give us any kind of updates from the ... now that the safety database...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 18 Feb 2009 10:25:19 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="tickers">AUXL,MS</category>
	</item>
	<item>
		<title><![CDATA[Auxilium Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-248614.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator instructions Your first question comes from the line of Marshall Urist from Morgan Stanley. Please proceed. Marshall Urist &#8211; Morgan Stanley Yes. Hey, guys, good morning. Armando, I was interested, obviously, in your comments about having the end of the partnership process in sight, so...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 12 Nov 2008 05:27:12 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/pressure.html"><![CDATA[Pressure]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/pressure.html"><![CDATA[Pressure]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="tickers">AUXL,MS</category>
	</item>
	<item>
		<title><![CDATA[Auxilium Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200809/ai_n28053606]]></link>
		<description><![CDATA[Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Morgan Stanley Global Healthcare Unplugged Conference to be held September 9, 2008 at The Grand Hyatt in New York City.  Mr. Armando Anido, Chief Executive Officer, is scheduled to present an overview of the Company...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 02 Sep 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[INTERNET]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="tickers">AUXL,MS</category>
	</item>
	<item>
		<title><![CDATA[Tuesday Options Outlook: SKF, GS, KRE, X, GDX, SIL, SWY, TTWO, AUXL]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F90556-tuesday-options-outlook-skf-gs-kre-x-gdx-sil-swy-ttwo-auxl%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Rebecca Engmann Darst co-authored this article.  Ultrashort Financial Proshares SKF ? News this morning Morgan Chase that it plans to write down $1.5 billion in mortgage backed assets amid ?substantially deteriorated? trading conditions ? coupled with an analyst downgrade of Goldman Sachs ? didn?t just provide a terse lesson...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 12 Aug 2008 09:21:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/goldman+sachs+group+inc..html"><![CDATA[Goldman Sachs Group Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/safeway+inc..html"><![CDATA[Safeway Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/take-two+interactive+software+inc..html"><![CDATA[Take-Two Interactive Software Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/united+states+steel+corp..html"><![CDATA[United States Steel Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SWY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TTWO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">X</category>
		<category domain="tickers">AUXL,GS,SWY,TTWO,X</category>
	</item>
	<item>
		<title><![CDATA[Auxilium Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-226832.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you. Operator Instructions. Your first question comes from the line of Salveen Kochnover, with Jefferies & Company. Please proceed. Salveen Kochnover - Jefferies & Company Sure. Hey, guys, good morning. Armando Anido Good morning, Salveen. Salveen Kochnover - Jefferies & Company Thank you for taking my...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 16 May 2008 14:46:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="tickers">AUXL</category>
	</item>
	<item>
		<title><![CDATA[Auxilium Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200804/ai_n25347463]]></link>
		<description><![CDATA[Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) today announced that executive management will participate in the Morgan Stanley Global Healthcare Unplugged Conference to be held April 30 - May 2, 2008, at The Ritz-Carlton, Key Biscayne in Florida.  Mr. Armando Anido, Chief Executive Officer and President, is scheduled to present an...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 24 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/morgan+stanley.html"><![CDATA[Morgan Stanley]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MS</category>
		<category domain="tickers">AUXL,MS</category>
	</item>
	<item>
		<title><![CDATA[Auxilium Pharmaceuticals Q4 2007 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-230037.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Salveen Kochnover of Jefferies. Please proceed. Salveen Kochnover - Jefferies Sure. Thanks for taking my questions. Armando, when you look at partnering XIAFLEX in the EU, are you looking at partnering it just for Dupuytren&#39;s or for...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 18 Feb 2008 16:14:07 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/auxilium+pharmaceuticals+inc..html"><![CDATA[Auxilium Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AUXL</category>
		<category domain="tickers">AUXL</category>
	</item>
</channel>
</rss>
